citrus/悪性腫瘍

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to regimens and therapeutics intended to inhibit the formation, progression and metastatic conversion of a variety of cancers in mammals, including humans. Cancers effectively targeted by this regimen include solid

FIELD OF THE INVENTION The present invention relates generally to methods for treating prostate cancer. BACKGROUND OF THE INVENTION The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United

1. INTRODUCTION The present invention relates to compositions and methods for the prevention and treatment of oncogenic disorders, atherosclerosis and hypercholesterolemia, with citrus limonoids, flavonoids and/or tocotrienols. Limonoids are a group of chemically related triterpene derivatives found

REFERENCE TO SEQUENCE LISTING The hard copy of the sequence listing submitted herewith and the corresponding computer readable form are both incorporated herein by reference in their entireties. FIELD OF INVENTION This invention relates to a citrus methoxyflavone and the use thereof for treating

FIELD OF THE INVENTION The present invention relates generally to methods for treating prostate cancer. BACKGROUND OF THE INVENTION The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United

BACKGROUND OF THE INVENTION It is known that certain naturally occurring non-nutritive agents present in plants and which can be extracted from the plants or fruits may exhibit medical therapeutic properties. In particular, it has been shown that certain flavonoid compounds isolated from citrus

TECHNICAL FIELD The invention concerns a method for the management of cancer and treatment cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, impaired cognitive function, loss of appetite, muscle weakness, nausea,

The invention relates to an antitumor agent of citrus limonoids. DESCRIPTION OF THE PRIOR ART Limonin and nomilin, along with other limonoids, are present in Rutaceous plants which include the common edible fruits; orange, lemon, lime, and grapefruit. The molecular structure of limonoids contains a

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

RELATED APPLICATIONS This application claims priority to Taiwan Application Serial Number 100141068, filed on Nov. 10, 2011, which is herein incorporated by reference. BACKGROUND 1. Field of Invention The present invention relates to a pectic enzyme treated pectin (PET-pectin) and a method of

PRIORITY DATA AND INCORPORATION BY REFERENCE This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention This invention pertains to

BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate

BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate